🟢 Devonian Health Group is trading 11.11% up — catalyst remains unclear

Devonian Health Group is trading 11.11% up at CA$7.50, with the move’s catalyst unclear.

• No verified company-specific announcement dated October 29 explains the increase; available market context is negative rather than a same-direction explanation.
• A Health Canada pediatric-trial authorization was reported in connection with Devonian, but it predates this session, and available reporting does not link it to the October 29 rise.